MSVMX Mutual Fund

MSVMX Mutual Fund

NAV$6.36
See how much of MSVMX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
2.05%
Dividend Yield (Current)
0.58%
Holdings
33
Inception Date
Dec 31, 2021
Fund Family
Morgan Stanley Investment Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+0.78%
1 Year+27.99%
3 Year+2.12%

Asset Allocation

Stocks: 98.41%
Cash: 1.59%
See how much of MSVMX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
ARGX:ASArgenx Se Sponsored Adr (1 Ads : 1 Ordinary)8.03%
LLYEli Lilly & Co.7.79%
ASND:COAscendis Pharma As Adr5.48%
NKTRNektar Therapeutics Class A4.75%
TMOThermo Fisherscientific Inc.4.28%
Top 10 Concentration: 49.11%Report Date: Mar 31, 2026
Download all 33 holdings for MSVMX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.58%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

MSVMX Mutual Fund Overview

MSVMX Mutual Fund (Vitality Portfolio Class C) is managed by Morgan Stanley Investment Management. MSVMX expense ratio is 2.05%, holding 33 positions across sectors including Health Care, Information Technology. Inception date: 2021-12-31.

MSVMX performance shows a YTD return of 0.78%. The 1-year return is 27.99%. MSVMX dividend yield stands at 0.58%, paid annually.

MSVMX top holdings include Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (8.0%), Eli Lilly & Co. (7.8%), Ascendis Pharma As Adr (5.5%), Nektar Therapeutics Class A (4.8%), Thermo Fisherscientific Inc. (4.3%). Go to all MSVMX holdings, MSVMX sectors, or MSVMX dividends.

MSVMX can be compared against other funds. Use MSVMX overlap to find shared positions, or MSVMX vs another fund for a side-by-side view. MSVMX alternatives are available via the screener, along with tax-loss harvesting opportunities.